1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Bone Regeneration - Pipeline Review, H1 2014

Bone Regeneration - Pipeline Review, H1 2014

  • April 2014
  • -
  • Global Markets Direct
  • -
  • 40 pages

Bone Regeneration - Pipeline Review, H1 2014

Summary

Global Markets Direct’s, ‘Bone Regeneration - Pipeline Review, H1 2014’, provides an overview of the Bone Regeneration’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Bone Regeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Regeneration and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Bone Regeneration
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Bone Regeneration and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Bone Regeneration products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Bone Regeneration pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Bone Regeneration
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Bone Regeneration pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Contents

Bone Regeneration - Pipeline Review, H1 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Bone Regeneration Overview 6
Therapeutics Development 7
Pipeline Products for Bone Regeneration - Overview 7
Pipeline Products fo Bone Regeneration - Comparative Analysis 8
Bone Regeneration - Therapeutics under Development by Companies 9
Bone Regeneration - Therapeutics under Investigation by Universities/Institutes 10
Bone Regeneration - Pipeline Products Glance 11
Early Stage Products 11
Bone Regeneration - Products under Development by Companies 12
Bone Regeneration - Products under Investigation by Universities/Institutes 13
Bone Regeneration - Companies Involved in Therapeutics Development 14
CYATHUS EXQUIRERE PharmaforschungsGmbH 14
GliaMed, Inc. 15
Histocell S.L. 16
Bioventus LLC 17
Samumed 18
Bone Regeneration - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
WX-04554 - Drug Profile 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
HR-004 - Drug Profile 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
Small Molecule to Activate Integrin Alpha 5 for Bone Repair And Regeneration - Drug Profile 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
Chordin - Drug Profile 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
Cyathus-1103-B - Drug Profile 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
GM-1485 - Drug Profile 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
Fibroblast Growth Factor Conjugate - Drug Profile 35
Product Description 35
Mechanism of Action 35
RandD Progress 35
Protein Fractions - Drug Profile 36
Product Description 36
Mechanism of Action 36
RandD Progress 36
Recombinant Proteins for Orthopaedic Healing - Drug Profile 37
Product Description 37
Mechanism of Action 37
RandD Progress 37
Bone Regeneration - Dormant Projects 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40

List of Tables

Number of Products under Development for Bone Regeneration, H1 2014 7
Number of Products under Development for Bone Regeneration - Comparative Analysis, H1 2014 8
Number of Products under Development by Companies, H1 2014 9
Number of Products under Investigation by Universities/Institutes, H1 2014 10
Comparative Analysis by Early Stage Development, H1 2014 11
Products under Development by Companies, H1 2014 12
Products under Investigation by Universities/Institutes, H1 2014 13
Bone Regeneration - Pipeline by CYATHUS EXQUIRERE PharmaforschungsGmbH, H1 2014 14
Bone Regeneration - Pipeline by GliaMed, Inc., H1 2014 15
Bone Regeneration - Pipeline by Histocell S.L., H1 2014 16
Bone Regeneration - Pipeline by Bioventus LLC, H1 2014 17
Bone Regeneration - Pipeline by Samumed, H1 2014 18
Assessment by Monotherapy Products, H1 2014 19
Number of Products by Stage and Target, H1 2014 21
Number of Products by Stage and Mechanism of Action, H1 2014 23
Number of Products by Stage and Route of Administration, H1 2014 25
Number of Products by Stage and Molecule Type, H1 2014 27
Bone Regeneration - Dormant Projects, H1 2014 38

List of Figures

Number of Products under Development for Bone Regeneration, H1 2014 7
Number of Products under Development for Bone Regeneration - Comparative Analysis, H1 2014 8
Number of Products under Development by Companies, H1 2014 9
Number of Products under Investigation by Universities/Institutes, H1 2014 10
Comparative Analysis by Early Stage Products, H1 2014 11
Assessment by Monotherapy Products, H1 2014 19
Number of Products by Top 10 Target, H1 2014 20
Number of Products by Stage and Top 10 Target, H1 2014 21
Number of Products by Top 10 Mechanism of Action, H1 2014 22
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 23
Number of Products by Top 10 Route of Administration, H1 2014 24
Number of Products by Stage and Top 10 Route of Administration, H1 2014 25
Number of Products by Top 10 Molecule Type, H1 2014 26
Number of Products by Stage and Top 10 Molecule Type, H1 2014 27

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Bone Regeneration Material Industry 2015 Market Research Report

Global Bone Regeneration Material Industry 2015 Market Research Report

  • $ 2800
  • Industry report
  • December 2015
  • by QY Research Group

Summary The Global Bone Regeneration Material Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Bone Regeneration Material industry. The report provides ...

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.